참고문헌
- Vastesaeger M, Gillot P, Rasson G. Etude clinique d'une nouvelle medication anti-angoreuse. Acta Cardiol 1967;22:483-500
- Charlier R, Deltour G, Baudine A, Chaillet F. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile. Arzniemittelforschung 1968; 18:1408-17
- Singh BN, Vaughan-Williams EM. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 1970;39:657-67 https://doi.org/10.1111/j.1476-5381.1970.tb09891.x
- Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkengerger RL, et al. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 1981;305:539-45 https://doi.org/10.1056/NEJM198109033051002
- Heger JJ, Prystowsky EN, Zipes DP. Relationships between amiodarone dosage, drug concentrations, and adverse side effects. Am Heart J 1983;106:931-5 https://doi.org/10.1016/0002-8703(83)90018-2
- Wilson BD, Clarkson CE, Lippman ML. Amiodarone induced pulmonary inflammation: correlation with drug dose and lung levels of drug, metabolite and phospholipid. Am Rev Respir Dis 1991;143:1110-4 https://doi.org/10.1164/ajrccm/143.5_Pt_1.1110
- Venet A, Gaubarrere I, Bonan G. Five cases of immune mediated amiodarone pneumonitis. Lancet 1984;1: 962-3
- Martin WJ 2nd, Rosenow EC 3rd. Amiodarone pulmonary toxicity. Chest 1988;93:1242-8 https://doi.org/10.1378/chest.93.6.1242
- Goldstein I, Topilsky M, Segev D, Isakov A, Heller I. Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. Chest 1997;111:1446-7 https://doi.org/10.1378/chest.111.5.1446
- Martin WJ 2nd, Rosenow EC 3rd. Amiodarone pulmonary toxicity: recognition and pathogenesis (part I). Chest 1988;93:1067-75 https://doi.org/10.1378/chest.93.5.1067
- Kwon KH, Jin SY, Park CS, Jeong SW, Uh ST, Kim YH, et al. A case of amiodarone: associated pulmonary toxicity. Korean J Intern Med 1995;10;155-9
- Kundenchuk PJ, Piersion DJ, Greene HL, Graham EL, Sears GK, Trobaugh GB. Prospective evaluation of amiodarone pulmonary toxicity. Chest 1984;86;541-8 https://doi.org/10.1378/chest.86.4.541
- Sobol SM, Rakita L. Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug. Circulation 1982;65:819-24 https://doi.org/10.1161/01.CIR.65.4.819
- Myers JL, Kennedy JI, Plumb VJ. Amiodarone lung: pathologic findings in clinically toxic patients. Hum Pathol 1987;18:349-54 https://doi.org/10.1016/S0046-8177(87)80164-8
- Vizioli LD, Cho S. Amiodarone: associated hemoptysis. Chest 1994;105:305-6 https://doi.org/10.1378/chest.105.1.305
- Dean PJ, Hroshart KD, Porterfield JG, Iansmith DH, Golden EB Jr. Amiodarone: associated pulmonary toxicity. Am J Clin Pathol 1987;87:7-13
- Iskander S, Raible DG, Brozena SC, Gaitanaru DM, Ayala G, Iskandrian AE. Acute alveolar hemorrhage and orthodeoxia induced by intravenous amiodarone. Catheter Cardiovascular Interv 1999;47:61-3 https://doi.org/10.1002/(SICI)1522-726X(199905)47:1<61::AID-CCD14>3.0.CO;2-C